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The ribosome is a major target in the bacterial cell for
antibiotics. Here, we dissect the effects that the
thiopeptide antibiotics thiostrepton (ThS) and micro-
coccin (MiC) as well as the orthosomycin antibiotic
evernimicin (Evn) have on translational GTPases.
We demonstrate that, like ThS, MiC is a translocation
inhibitor, and that the activation by MiC of the ribo-
some-dependent GTPase activity of EF-G is depen-
dent on the presence of the ribosomal proteins L7/
L12 as well as the G0 subdomain of EF-G. In contrast,
Evn does not inhibit translocation but is a potent
inhibitor of back-translocation as well as IF2-depen-
dent 70S-initiation complex formation. Collectively,
these results shed insight not only into fundamental
aspects of translation but also into the unappreci-
ated specificities of these classes of translational
inhibitors.
INTRODUCTION
Protein synthesis occurs on large macromolecular particles
called ribosomes, which are composed of RNA and protein. In
bacteria the 70S ribosome can be split into a small (30S) and
large (50S) subunit. The bacterial translational machinery repre-
sents a major target within the cell for antibiotics (reviewed by
Blanchard et al., 2010; Wilson, 2009). Many clinically important
classes of antibiotics inhibit translation by binding to the active
centers of ribosome. For example the tetracyclines and amino-
glycosides bind at the decoding site on the small subunit, and
the chloramphenicols, macrolides/ketolides, oxazolidinones,
and lincosamides bind at the peptidyltransferase center (PTC)
on the large subunit (Sohmen et al., 2009a, 2009b). Despite the
potency of many of these drug classes, antibiotic resistance
among clinically relevant pathogens is an increasing problem,
and thus, the need for new antibiotics is more urgent than ever
before. Ideally, the new antibiotics should have nonoverlapping
sites with the currently used antimicrobial agents, so that theChemistry & Biology 18,occurrence of cross-resistance is reduced or prevented. Two
such classes are the thiopeptides and orthosomycins (Figures
1A–1C), which bind to distinct sites on the large ribosomal
subunit that are located far from the PTC (Figures 1D and 1E).
The orthosomycins, such as evernimicin (Evn), are oligosac-
charide antibiotics (Figure 1A) that display excellent antimicro-
bial activity against a broad range of Gram-positive bacteria,
both in vivo and in vitro. Although attempts to introduce Evn clin-
ically as Ziracin (Schering-Plough) were unsuccessful, a related
compound, avilamycin (Avn), is used as a growth promoter in
animal feeding. A multitude of resistance mutation/modification
and chemical footprinting studies indicate that the orthosomy-
cin-binding site is located at the base of the L7/L12 stalk (Figures
1D and 1E), 50 A˚ from the PTC. Mutations in ribosomal protein
L16 (Aarestrup and Jensen, 2000; Adrian et al., 2000b;McNicho-
las et al., 2001; Zarazaga et al., 2002), and in helix 89 (H89) and
H91 of the 23S rRNA, as well as methylation of G2470 (E. coli
numbering used throughout) in H89 (Mann et al., 2001), confer
resistance to Evn and Avn (Adrian et al., 2000a; Belova
et al., 2001). In addition, Evn and Avn protect 23S rRNA nucleo-
tides, e.g., A2482 in H89 and A2534 in H91, from chemical modi-
fication (Belova et al., 2001; Kofoed and Vester, 2002). It is also
noteworthy that mutations in rplP (L16 gene) confer relatively
low-level resistance (MIC <12 mg ml1), whereas higher-level
resistance (MIC >256 mg ml1) is obtained by EmtA-mediated
methylation or rRNA mutations (Belova et al., 2001; Mann
et al., 2001). Taken together, these results suggest that the
orthosomycin-binding site spans from the minor groove of H89
to the loop region of H91 (Figure 1E) and that mutations in L16
confer resistance indirectly via perturbation of the 23S rRNA.
In agreement with this novel location, Evn does not inhibit
peptide-bond formation (Belova et al., 2001) or compete
with several other ribosomal antibiotics for ribosome binding
(McNicholas et al., 2000). Although some effect of Avn on
aa-tRNA binding to ribosomes has been observed (Wolf,
1973), Evn is better known as an initiation inhibitor; Evn inhibits
the formation of fMet-puromycin in an IF2-dependent manner
(Belova et al., 2001), although the exact step of inhibition remains
unclear. Moreover, to our knowledge, the effects of orthosomy-
cins on translation factors other than IF2 and EF-Tu have not yet
been addressed.589–600, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 589
Figure 1. Chemical Structures and Ribosomal-Binding Sites of Thiopeptide and Orthosomycin Antibiotics
(A–C) Chemical structures of the (A) orthosomycin Evn, and the thiopeptide antibiotics (B) ThS and (C) MiC.
(D) Overview of the binding sites of orthosomycins and thiopeptides on the large subunit relative to EF-G. R-proteins L1, L11, and L7 are shown for reference.
(E) Putative binding site of orthosomycins spanning fromH89 and H91 of the 23S rRNA. Residues highlighted in red have been associated biochemically with Evn
or Avn (reviewed by Wilson, 2009).
(F) Binding site of ThS (green) in the cleft between H43 and H44 of the 23S rRNA and the NTD of L11 (L11-ThS) (Harms et al., 2008). The relative positions of EF-G
(blue), C-terminal domain of L7/L12 (L7-CTD), and of a different conformation of L11 (L11-EF-G) are from Gao et al. (2009).
(G) Overview of domain arrangement of EF-G with contact between the L7-CTD and the G0 domain of EF-G as observed in the 70S-EF-G crystal structure (Gao
et al., 2009).
(H) Expansion of (G) highlighting the secondary structure elements of the G0 subdomain.
(I) Juxtaposition of the G0 subdomain of EF-G (gray transparency) with the G-domain of EF4 (orange) (Evans et al., 2008) that lacks a G0 subdomain.
See also Figure S1.
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Thiopeptide and Orthosomycin Action on RibosomesIn contrast, thiopeptides, such as thiostrepton (ThS), have
been extensively studied (reviewed by Bagley et al., 2005;
Nicolaou et al., 2009; Wilson, 2009). Although ThS is already in
veterinary usage, its low water solubility and poor bioavailability
has so far precluded its use in human medicine. Nevertheless,
the thiopeptide class of antibiotics has received renewed
interest in the recent years because (i) of its effectiveness
against Gram-positive bacteria, in particular,methicillin-resistant
Staphylococcus aureus (MRSA), andagainst themalarial parasite
Plasmodium falciparum (McConkey et al., 1997), as well as (ii)590 Chemistry & Biology 18, 589–600, May 27, 2011 ª2011 Elsevierrecent successes in the total synthesis of a number of thiopepti-
des (reviewed by Hughes and Moody, 2007; Nicolaou et al.,
2009), including among others, ThS (Nicolaou et al., 2005a,
2005b) and micrococcin (MiC) (Lefranc and Ciufolini, 2009).
Thiopeptide antibiotics, such as ThS and MiC, are composed of
oxazoles and thiazoles, as well as nonnatural amino acids that
are linked together to form complex macrocyclic frameworks
(Figures 1B and 1C).
Both ThS and MiC have been crystallized in complex with the
large ribosomal subunit, revealing their binding site to be locatedLtd All rights reserved
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Thiopeptide and Orthosomycin Action on Ribosomesin a cleft formed by the N-terminal domain (NTD) of ribosomal
protein L11 and H43/H44 of the 23S rRNA (Figures 1D and 1F)
(Harms et al., 2008), consistent with a vast wealth of prior
biochemical studies (reviewed by Wilson, 2009). This region is
part of the GTPase-associated center (GAC), so named because
it is involved in binding of translation factors and stimulation of
their GTPase activities. Consistently, thiopeptide antibiotics
have been shown to inhibit IF2-dependent 70S-initiation
complex (70SIC) formation (Brandi et al., 2004; Grigoriadou
et al., 2007), EF-Tu-dependent delivery of aminoacyl-tRNAs to
the ribosome (Brandi et al., 2004; Gonzalez et al., 2007; Modolell
et al., 1971; Otaka and Kaji, 1974), translocation of the tRNA2-
mRNA complex through the ribosome (Munro et al., 2010; Pan
et al., 2007; Pestka, 1970; Pestka and Brot, 1971; Rodnina
et al., 1997), and stringent factor RelA-dependent synthesis of
ppGpp (Cundliffe and Thompson, 1981; Knutsson Jenvert and
Holmberg Schiavone, 2005). Surprisingly, however, ThS and
MiC exhibit differential effects on the uncoupled ribosome-
dependent EF-G GTPase activities: ThS strongly inhibits
multiple-turnover GTP hydrolysis of EF-G (Pestka, 1970; Weis-
blum and Demohn, 1970) by preventing inorganic phosphate
(Pi) release and, thus, trapping EF-G on the ribosome (Rodnina
et al., 1999; Seo et al., 2006). The overlap between the ThS
and EF-G binding sites on the ribosome (Figures 1D and 1F)
(Harms et al., 2008) suggests that ThS stabilizes an initial binding
state of EF-G (Rodnina et al., 1999; Seo et al., 2006), which has
weaker affinity than a subsequently formed, accommodated
state (Cameron et al., 2002; Seo et al., 2006). In contrast, MiC
does not prevent Pi release (Starosta et al., 2009) and actually
stimulates the multiple-turnover GTP hydrolysis activity of EF-
G (Cameron et al., 2002; Cundliffe and Thompson, 1981; Lentzen
et al., 2003).
The G domains of translational GTPases have a well-
conserved architecture, with the exception of a region located
between the G4 and G5 motifs, which, in EF-G, are termed the
G0 subdomain (see Figure S1 available online). In EF-G the G0
subdomain consists of 90 amino acids that form four consec-
utive b strands (2G–5G) followed by three a helices (AG–CG)
(Figures 1G and 1H; Figure S1). In contrast, translational
GTPases, such as elongation factor EF-Tu, initiation factor IF2,
the ribosome-associated stress response factor BipA (deLivron
et al., 2009; deLivron and Robinson, 2008; Owens et al., 2004),
and the back-translocation factor LepA (EF4) (Liu et al., 2010;
Qin et al., 2006), are completely lacking the G0 subdomain (Fig-
ure 1I), whereas the ribosomal protection protein TetM (Connell
et al., 2003a) has a partial G0 subdomain, lacking three b strands
(3G–5G) (Figure S1). Interaction of the G
0 subdomain of EF-G with
the C-terminal domain of ribosomal protein L7/L12 (L7-CTD) is
observed structurally (Connell et al., 2007; Datta et al., 2005;
Gao et al., 2009; Harms et al., 2008; Helgstrand et al., 2007)
(Figures 1G and 1H) and is required for efficient GTP hydrolysis
(Diaconu et al., 2005; Nechifor et al., 2007; Savelsbergh et al.,
2000, 2005) and Pi release (Diaconu et al., 2005; Savelsbergh
et al., 2005), leading to the suggestion that enhanced recycling
of EF-G by MiC results from stabilization of this interaction
(Harms et al., 2008).
Here, we show that although MiC stimulates the multiple-turn-
over ribosome-dependent EF-G GTPase, it inhibits the GTPase
activities of other translational GTPases, such as TetM, EF4,Chemistry & Biology 18,BipA, and IF2, which have reduced, or completely absent, G0
subdomains. Furthermore, deletion of the G0 subdomain from
EF-G removes the stimulatory effect of MiC, as does the
absence of L7/L12 on the ribosome. Despite the differential
effects of MiC and ThS on EF-G GTPase, we show that MiC,
like ThS, is a potent inhibitor of the EF-G catalyzed translocation
process. In contrast the orthosomycin Evn, although not inter-
fering with EF-G GTPase and translocation activities, is a potent
inhibitor of the ribosome-dependent IF2 and EF4 GTPase activ-
ities, as well as of EF4-mediated back-translocation and IF2-
dependent 70SIC formation. Collectively, our results delineate
the specific steps of interference and reveal the differential
effects that these inhibitors have on translocation factor func-
tion—an important step for the development of new, improved
antimicrobial agents.
RESULTS
Differential Effects of Thiopeptide Antibiotics
on GTPase Activities of Translational Factors
The suggestion that MiC stimulates the uncoupled ribosome-
dependent GTPase (rdGTPase) of EF-G by stabilizing the inter-
action of L7-CTD with the G0 subdomain of EF-G (Harms et al.,
2008) prompted us to investigate the effect of MiC on the un-
coupled rdGTPase activities of other translational GTPases
that have reduced or completely absent G0 subdomains (such
as TetM, EF4, and BipA), as determined using the malachite
green assay (Starosta et al., 2009). We found rdGTPase activity
of EF-G to be inhibited by ThS (Figure 2A), as expected from
previous reports (Pan et al., 2007; Pestka, 1970; Rodnina et al.,
1999; Weisblum and Demohn, 1970). The rdGTPase activities
of TetM, EF4, andBipAwere also inhibited by ThS (1 mM) (Figures
2B–2D), as was the rdGTPase activity of IF2 (Figure 2E), as re-
ported previously (Grunberg-Manago et al., 1972). Similar trends
were found for all factors independent of the excess of the factor
over the ribosome (Figure S2) or the concentration of antibiotics
used (data not shown). Consistent with these results, ThS has
been shown previously to inhibit the rdGTPase activity of
a related ribosome protection protein, TetO (Connell et al.,
2003b), the formation of a stable complex between TetM and
the ribosome in the presence of GDPNP and GTP (Dantley
et al., 1998), and the IF2-dependent formation of 70SIC (Grigor-
iadou et al., 2007). However, we could not reproduce the recently
reported stimulatory effects of ThS on IF2 GTPase (Brandi et al.,
2004; Cameron et al., 2002).
Guided by a comparison of the crystal structures of T. thermo-
philus EF-G (PDB 1FNM; Laurberg et al., 2000) with E. coli EF4
(PDB 3CB4; Evans et al., 2008), we also generated an E. coli
EF-G lacking the G0 subdomain (EF-GDG0): EF-GDG0 has a
deletion of amino acids 172–265, thus truncating the G0 subdo-
main before b3G and after b61 (Figure S1). In contrast to previous
attempts to produce an EF-GDG0 protein (Nechifor et al., 2007),
soluble protein was obtained under native conditions, and
therefore, refolding or purification under denaturing conditions
was unnecessary (see Experimental Procedures). The purified
E. coli EF-GDG0 had an intrinsic GTPase activity comparable
with that of wild-type E. coli EF-G (data not shown), suggesting
that the protein was not misfolded. Moreover, although the
rdGTPase was significantly slower (>103) than wild-type589–600, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 591
Figure 2. Effect of ThS and MiC on GTPase Activity of Various Translation Factors
(A–F) The rdGTPase activities of translation factors (A) E. coli EF-G, (B) TetM, (C) E. coli EF4, (D) E. coliBipA, (E) E. coli IF2, and (F) E. coliEF-GDG0, usingE. coli 70S
ribosomes in the absence (black circles) and presence of 1 mM ThS (red squares) or 5 mM MiC (blue triangles).
(G–I) The rdGTPase activities of E. coli translation factors (G) EF-G, (H) EF4, and (I) BipA, using E. coli 70S ribosomes lacking L7/L12. Reactions in (G)–(I) were
incubated for 12 hr at 20C.
In all cases, background hydrolysis due to the intrinsic GTPase activity of each factor has been subtracted. See also Figure S2.
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Thiopeptide and Orthosomycin Action on RibosomesE. coli EF-G, it was nevertheless inhibited by ThS (Figure 2F),
albeit more weakly than for wild-type EF-G. As expected from
previous studies (Cameron et al., 2002; Cundliffe and Thomp-
son, 1981; Lentzen et al., 2003), we also observed that MiC
enhanced the rdGTPase activity of EF-G (Figure 2A). Conversely,
we could show thatMiC inhibited the rdGTPase of all other trans-
lational GTPases that were tested, namely TetM, EF4, BipA, and
IF2 (Figures 2B–2E). Additionally, deletion of the G0 subdomain of
EF-G also produced a change in the activity of MiC becauseMiC
was seen to inhibit, rather than stimulate, the rdGTPase of EF-
GDG0 (Figure 2F). We note that deletion of the G0 subdomain of
EF-G greatly reduced (>10-fold) the rdGTPase activity of the
factor, similar to the previously reported introduction of muta-
tions within aAG of the G
0 subdomain (Nechifor et al., 2007).
Similarly, ThS and MiC also inhibited the rdGTPase activities of
EF-G, EF4, and BipA when E. coli 70S ribosomes were used592 Chemistry & Biology 18, 589–600, May 27, 2011 ª2011 Elsevierthat lacked L7/L12 (70SDL7/L12) (Figures 2G–2I). Defects in
rdGTPase of EF-G have also been seen when the ribosomal
proteins L7/L12 are selectively removed from the ribosome
(Diaconu et al., 2005; Kischa et al., 1971; Nechifor et al., 2007)
or mutations are made within the L7-CTD (Diaconu et al., 2005).
Inhibition of Translocation by Thiopeptide Antibiotics,
but Not by Evn
The translocation reaction occurs after peptide-bond formation
and involves the EF-G catalyzed movement of the peptidyl-
and deacylated-tRNAs in the A and P sites into the P and E sites,
respectively (Figure 3A) (reviewed by Schmeing and Rama-
krishnan, 2009). Conversion of the pretranslocational (PRE)
complex into a posttranslocational (POST) complex proceeds
through (A/P and P/E) hybrid states, where the CCA 30 ends of
the tRNAsmovewith respect to the large subunit while remainingLtd All rights reserved
Figure 3. Effect of the MiC and Evn on Translocation
(A) Scheme for EF-G catalyzed translocation with sites of antibiotic inhibition.
(B) Isolated PRE complex (0.1 mM) containing yeast fMetPhe-tRNAPhe(Prf16/17) in the A site and tRNAfMet in the P site, either in the absence of antibiotic (black
trace) or in the presence of ThS (10 mM; red trace) or MiC (10 mM; blue trace), was rapidly mixed in a stopped-flow spectrophotometer with 5 mMEF-G and 1 mM
GTP.
(C) Isolated PRE complex (0.1 mM) containing E. coli fMetPhe-tRNAPhe(Prf16/20) and tRNAfMet in the P site, in the absence of antibiotic (black trace) or in the
presence of Evn (10 mM; green trace) or MiC (10 mM; blue trace), was rapidly mixed in a stopped-flow spectrophotometer with 5 mM EF-G and 1 mM GTP. All
concentrations are final after mixing. The traces in the control and +Evn traces are each fit to a two-step process (Pan et al., 2007) yielding the following rate
constants: Control: 20.7 ± 0.6 s1, 1.3 ± 0.1 s1; +Evn: 28.1 ± 0.7 s1, 3.5 ± 0.2 s1.
See also Figure S3.
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2004; Moazed and Noller, 1989; Ratje et al., 2010). To monitor
translocation rates, PRE complexes were assembled containing
proflavin (prf)-labeled tRNAs, thus enabling tRNA movement to
be followed by stopped-flow monitoring of the fluorescence
change following delivery of EF-G,GTP (Pan et al., 2007;
Rodnina et al., 1997; Savelsbergh et al., 2003). In Figure 3B,
rapid addition of EF-G,GTP to PRE complexes formed with un-
labelled E. coli tRNAf
Met in the P site and yeast fMetPhe-tRNAPhe
(prf16/17) in the A site leads to an apparent monophasic increase
in fluorescence as A-site tRNA is translocated to the P site (Pan
et al., 2007; Rodnina et al., 1997; Savelsbergh et al., 2003).
Preincubation of the PRE complex with (10 mM) MiC or ThS
completely abolished fluorescence, as reported previously for
ThS (Pan et al., 2007; Rodnina et al., 1997).
By contrast, translocation clearly proceeds via a two-step
reaction for PRE complexes containing E. coli tRNAf
Met in the
P site and E. coli fMetPhe-tRNAPhe (Prf16/20) in the A site (Fig-
ure 3C) (Pan et al., 2007). In this case an initial rapid increase
in fluorescence intensity is followed by a gradual decrease,
with respective apparent rate constants of 20.7 ± 0.6 s1 and
1.3 ± 0.1 s1. The presence of MiC abolishes almost all fluores-Chemistry & Biology 18,cent change (Figure 3C), strongly inhibiting step 1 and, thus, step
2, as reported previously for ThS (Pan et al., 2007). In contrast,
Evn does not inhibit the translocation reaction. In fact the
apparent rate constants (step 1, 28.1 ± 0.7 s1; step 2, 3.5 ±
0.2 s1) suggest that the drug actually accelerates the process,
particularly the second step (Figure 3C).
Evn Inhibits IF2-Dependent 70SIC Formation
In bacteria, formation of the 70SIC involves the association of
the large 50S subunit with a 30S-initiation complex (30SIC)
comprising the 30S subunit, mRNA; initiator fMet-tRNA and
three initiation factors IF1, IF2, and IF3 (Figure 4A) (reviewed by
Laursen et al., 2005; Simonetti et al., 2009). Binding of the 50S
subunit to the 30SIC stimulates the GTPase activity of IF2,
leading to release of IF2,GDP and resulting in a puromycin-reac-
tive 70SIC (Figure 4A) (Grigoriadou et al., 2007).
Evn has previously been shown to inhibit IF2-dependent
formation of fMet-puromycin (Belova et al., 2001), leading to its
classification as a translation initiation inhibitor. However, to
our knowledge, the exact step of inhibition has not been deter-
mined. To examine this further, 70SIC formation has been moni-
tored kinetically using light scattering as described previously589–600, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 593
Figure 4. Evn Inhibits IF2-Dependent 70SIC Formation
(A) Scheme for 70SIC formation with site of Evn inhibition.
(B) 30SIC (0.3 mM) was premixed with various concentrations of Evn (0–5 mM) and then rapidly mixed with 50S subunits (0.3 mM) in a KinTek stopped-flow
spectrophotometer. The sample from which IF2 was omitted demonstrates the dependence of 70SIC formation on IF2.
(C) A plot of the reciprocal of IF2-dependent light-scattering increase at 1 s versus Evn concentration, allowing calculation of an apparent Ki for Evn of 1.8 ±
0.2 mM.
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mRNA was rapidly mixed with 50S subunits, and the increase
in light scattering due to 70SIC formation (black control trace
in Figure 4B) was monitored using stopped-flow spectropho-
tometry. In the absence of IF2, no increase in light scattering
was observed (blue trace in Figure 4B), illustrating the IF2-
dependence for 70SIC reported previously (Antoun et al., 2006;
Grigoriadou et al., 2007). Pre-incubation of the 30SIC with
increasing concentrations of Evnbefore 50Saddition led to a cor-
responding decrease in IF2-dependent light scattering (green
traces in Figure 4B). At 5 mM Evn, almost all IF2-dependent light
scattering was abolished, indicating that Evn inhibits the IF2-
dependent association of the 30SIC with the 50S subunit. A
plot of the reciprocal of the increase of IF2-dependent light
scattering at 1 s versus Evn concentration (Figure 4C) yields an
apparent Ki for Evn of 1.8 ± 0.2 mM.
Differential Effects of Evn on GTPase Activity
of Translational GTPases
Evn strongly inhibits the rdGTPase activity of IF2 (Figure 5A) but
has little or no effect on the rdGTPase activities of EF-G (Fig-
ure 5B), or EF-GDG0 (Figure 5C), or of the EF-G paralog Tet(M)
(Figure 5D), consistent with the potency of Evn in inhibiting
70SIC formation (Figure 4B) and with the lack of effect of Evn
on EF-G-dependent translocation (Figure 3C). Surprisingly, Evn594 Chemistry & Biology 18, 589–600, May 27, 2011 ª2011 Elsevierwas also found to inhibit the rdGTPase of BipA (Figure 5E) and
especially EF4 (Figure 5F). Indeed, the inhibitory activity of Evn
toward EF4 (IC50 = 3 mM) was higher than that toward IF2
(IC50 = 7 mM), and much higher than toward BipA (IC50 =
20 mM).
EF4-Dependent Back-Translocation Is Inhibited by Evn
EF4 catalyzes partial back-translocation, i.e., the movements of
mRNA and tRNAs from POST toward the PRE state (Figure 6A)
(Liu et al., 2010; Qin et al., 2006). As described previously (Liu
et al., 2010), EF4-mediated partial back-translocation wasmoni-
tored using prf-labeled tRNAs: POST state ribosomes containing
fMetPhe-tRNAPhe(Prf16/20) in the P site and tRNAfMet in the E
site were rapidly mixed in a stopped-flow spectrophotometer
with EF4 and GDPNP, with fluorescence change being moni-
tored over time (Figure 6B). In the absence of antibiotic, back-
translocation proceeds via a three-step process (blue trace in
Figure 6B) consistent with movement through a series of three
intermediate states as reported (Liu et al., 2010) (INT1–3 in Fig-
ure 6A). In the presence of increasing concentrations of Evn,
both the fluorescence change and rates of each step in the
partial back-translocation were inhibited by Evn, (Figure 6B),
leading to an apparent Ki for Evn binding to the POST complex
of 0.6 mM (Figure 6C). High concentrations of Evn (5 mM in Fig-
ure 6B) completely abolished the EF4-catalyzed component ofLtd All rights reserved
Figure 5. Effect of Evn on the GTPase Activity of Various Translation Factors
(A–F) Activation of uncoupled rdGTPases of translation factors (A) E. coli IF2, (B) E. coli EF-G, (C) E. coli EF-GDG0, (D) S. faecalis TetM, (E) E. coli BipA, and (F)
E. coli EF4, in the presence of increasing concentrations of Evn. The inset shows the color gradient scale from 0 (yellow) to 800 pmol (blue) of Pi produced per pmol
of 70S ribosomes, following subtraction of background intrinsic GTPase activities.
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reverse-translocation process that occurs in the absence of
EF4 was observed (Liu et al., 2010). Evn inhibition of EF4-depen-
dent partial back-translocation is similar to that reported earlier
using spectinomycin (Liu et al., 2010), a well-characterized trans-
location inhibitor (Wilson, 2009), and is consistent with the obser-
vation that Evn is a potent inhibitor of the EF4 rdGTPase activity
(Figure 5F).
DISCUSSION
Influence of Thiopeptides on Translocation
and Translation Factor GTPase Activities
Although both ThS and MiC inhibit the multiple-turnover
rdGTPase activities of IF2, TetM, EF4, and BipA (Figures 2B–
2E), MiC differs from ThS in stimulating the rdGTPase of EF-G,
an activity that is strongly inhibited by ThS (Figure 2A). Our
results suggest that ThS inhibition and MiC stimulation of EF-G
rdGTPase arise ultimately from differential effects on the interac-
tions between the G0 subdomain of EF-G and L7-CTD.
ThS allows ribosome-binding and single-turnover GTPase
activity of EF-G but prevents the stable accommodation of
EF-G on the ribosome, which is necessary for tRNA translocation
(Rodnina et al., 1999; Seo et al., 2006). Part of the accommoda-
tion of EF-G encompasses the movement of EF-G toward
L11-NTD, which is inhibited by ThS (Seo et al., 2006), consistent
with the structural overlap between the binding site of ThS and
domain V of EF-G, both locating to the cleft formed by H43/44
and L11-NTD (Figure 1F) (Harms et al., 2008). Because ThSChemistry & Biology 18,also prevents multiple-turnover GTPase activity of EF-G by
inhibiting Pi release (Savelsbergh et al., 2003; Seo et al., 2006),
EF-G remains trapped on the ribosome but in an unaccommo-
dated state. In contrast, MiC allows Pi release from EF-G
(Starosta et al., 2009) and, thus, stimulates the multiple-turnover
rdGTPase activity of EF-G, as observed here (Figure 2A) and
reported previously (Cameron et al., 2002; Cundliffe and
Thompson, 1981; Lentzen et al., 2003). In agreement with the
idea that MiC stimulates the rdGTPase of EF-G by stabilization
of the interaction between the L7-CTD and the G0 subdomain
of EF-G (Harms et al., 2008), we could show that theMiC-depen-
dent stimulation of EF-G rdGTPase activity was lost when the G0
subdomain of EF-G was removed (Figure 2F) or the ribosomes
lacked L7/L12 (Figures 2G–2I). Moreover, the rdGTPase
activities of translation factors that naturally lack or have a
reduced G0 subdomain (TetM, EF4, BipA, IF2) were also inhibited
by MiC (Figures 2B–2E).
Although many translation factors lack the complete G0
subdomain, NMR studies indicate that IF2, EF-Tu, and RF3
interact with the same conserved region of L7-CTD as EF-G
(Helgstrand et al., 2007). L7/L12 has been proposed to interact
with helix aD1 of domain I of EF-Tu. However, this interaction is
more important for initial binding of EF-Tu,GTP,aa-tRNA to
the ribosome, rather than for subsequent steps, such as A-site
binding andGTPase activation (Kothe et al., 2004). Nevertheless,
like EF-G, the rdGTPase activity of EF-Tu is dramatically reduced
when ribosomes are depleted of L7/L12 (Diaconu et al., 2005;
Mohr et al., 2002). In contrast, depletion of L7/L12 reduces the
rate of association of IF2 with the ribosome, rather than directly589–600, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 595
Figure 6. Evn Inhibits EF4-Mediated Back-Translocation
(A) Scheme for EF4-catalyzed back-translocation with sites of antibiotic inhibition.
(B) Fluorescence changes over different time scales. Isolated POST complex (0.1 mM) containing fMetPhe-tRNAPhe(Prf) in the P site and tRNAfMet in the E site,
premixed with 0.15 mM tRNAfMet, to increase E-site occupancy, were rapidly mixed in a stopped-flow spectrophotometer with 3 mM EF4, 0.5 mM GDPNP, and
different concentrations of Evn as indicated on the figure. All concentrations are final aftermixing. Lines through the traces are fit to a kineticmodel (Liu et al., 2010)
in which back-translocation proceeds via a three-step process in the absence of Evn (the first two of which are catalyzed by EF4) and via a two-step process at
saturating Evn.
(C) A plot of the reciprocal of the apparent magnitude of the fluorescence change for the second, EF4-catalyzed step versus Evn concentration, giving an
apparent Ki for Evn binding to the POST complex of 0.6 ± 0.1 mM.
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observed that the rdGTPase of LepA and BipA with 70SDL7/L12
was significantly reduced but was also inhibited by bothMiC and
ThS (Figures 2H and 2I). Further work will be needed to distin-
guish between factor binding versus GTPase activity defects.
Despite the contrasting effects of MiC and ThS on the GTPase
activities of EF-G (Figure 2A) (Cameron et al., 2002; Cundliffe and
Thompson, 1981; Lentzen et al., 2003), our kinetic analysis
demonstrates thatMiC, like ThS, is a potent inhibitor of the trans-
location reaction (Figure 3B). The finding that MiC targets trans-
location is in agreement with original conclusions of Pestka and
Brot (1971), which were based upon its inhibition of poly(U)-
dependent poly(Phe) synthesis but its lack of affect on either
aa-tRNA binding or peptide-bond formation. Given the similarity
in binding site between MiC and ThS, it thus appears likely that
both MiC and ThS inhibit translocation analogously—namely,
by preventing the transition of EF-G from an initially weaker
binding state to a fully accommodated state on the ribosome,
which, we would suggest, is necessary for translocation (Seo
et al., 2006). We note that despite their diverse effects on the
rdGTPase of EF-G, the inhibitory potency of MiC and ThS with
respect to in vitro transcription-translation systems is compa-
rable (both have an IC50 of 3 mM) (Figure S3).596 Chemistry & Biology 18, 589–600, May 27, 2011 ª2011 ElsevierInfluence of the Orthosomycin Evn on Translation
Factor Activities
Unlike thiopeptides, we find that the orthosomycin Evn has no
inhibitory effect on rdGTPase activity of EF-G (Figure 5B) or on
the EF-G-mediated translocation reaction (Figure 3C). This is
consistent with the lack of overlap between the putative Evn-
binding site and the binding position of EF-G determined by
structural studies (Connell et al., 2007; Gao et al., 2009; Ratje
et al., 2010) (Figure 7A). Similarly, Evn does not inhibit the
rdGTPase of Tet(M) (Figure 5D) or of Tet(O) (data not shown),
which interacts with the ribosome in an analogous manner to
EF-G (Spahn et al., 2001). In contrast we find that Evn is a potent
inhibitor of the rdGTPase activity of IF2 (Figure 5A), BipA, and
EF4 (Figures 5E and 5F). Although little is known about the struc-
ture or function of BipA on the ribosome (deLivron et al., 2009),
structures of EF4 alone (Evans et al., 2008) and bound to the
ribosome (Connell et al., 2008) reveal an overall similarity with
EF-G. One exception is the unique CTD of EF4 (Evans et al.,
2008), which on the ribosome is oriented back toward the large
subunit (Connell et al., 2008) and encroaches upon the Evn-
binding site (Figure 7B). Such overlap is consistent with our
finding that Evn is a potent inhibitor EF4-mediated back-translo-
cation reaction (Figure 6B). Our results demonstrating potentLtd All rights reserved
Figure 7. Putative Binding Sites of Orthosomycin Antibiotics Relative to Translation Factors EF-G, EF4, and IF2
(A–C) Relative position of (A) EF-G (blue) (Connell et al., 2007; Gao et al., 2009), (B) EF4 (orange) (Connell et al., 2008), and (C) IF2 (purple) (Allen et al., 2005; Marzi
et al., 2003) to the putative Evn-binding site (encircled in red) (Belova et al., 2001; Wilson, 2009). Nucleotides associated with Evn binding in H89 and H91 are
colored red, and L16 (teal) is shown for reference. Note the overlap in positions of the CTD of EF4 and domain 4 (d4) of IF2 with the putative Evn-binding site.
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BipA and EF4, suggest that Evn can no longer be considered
exclusively as an initiation inhibitor, as it has been heretofore.
Indeed, Evn is a slightly stronger inhibitor of the rdGTPase
activity of EF4 compared with IF2, and the Ki (0.6 mM) for Evn
binding to the POST complex (Figure 6C) is a little lower than
the Ki (1.8 mM) for Evn inhibition of IF2-dependent 70SIC
formation.
Nevertheless, because the gene for EF4 is not essential for
survival in E. coli (Dibb and Wolfe, 1986), the principal antimicro-
bial target of Evn is most likely IF2. Here, we demonstrate that
Evn can inhibit the rdGTPase activity of IF2 (Figure 5A) as well
as prevent the IF2-dependent association of the 30SIC with
the large ribosomal subunit (Figure 4B). These findings support
an earlier suggestion that Evn inhibits 70SIC formation, which
was based on the ability of Evn to prevent the formation of
fMet-puromycin in an IF2-dependent manner (Belova et al.,
2001). Models for IF2 bound to the ribosome derived from
biochemical (Marzi et al., 2003) and cryo-EM data (Allen et al.,
2005; Myasnikov et al., 2005) suggest that domain 4 of IF2 and
the associated linker region encroach on the Evn-binding site
(Figure 7C). Thus, we believe that Evn sterically interferes with
IF2 binding to the large ribosomal subunit, accounting for the
Evn-dependent reduction in rdGTPase activity of IF2 with 70S
ribosomes (Figure 5A) as well as the reduction in 70SIC as
observed using light scattering (Figure 4B). The similarity
between the Ki (1.8 mM) of Evn inhibition for 70SIC formation
and the half-inhibitory concentration (IC50 = 2 mM) of Evn for
synthesis of GFP as measured in an E. coli in vitro-coupled tran-
scription-translation system (Figure S3) also supports the claim
that Evn targets predominantly the initiation phase of protein
synthesis (Belova et al., 2001).
SIGNIFICANCE
Insight into the mechanism of action of diverse classes of
antibiotics, such as the thiopeptides and orthosomycins,
to inhibit distinct steps during translation can provideChemistry & Biology 18,insight into the fundamental process of translation. Here,
we demonstrate that although the thiopeptides MiC and
ThS have contrasting effects on the rdGTPase activity of
EF-G, both antibiotics are potent inhibitors of EF-G-depen-
dent translocation reaction. Our results demonstrate that
the MiC-dependent stimulation of the rdGTPase of EF-G
requires the presence of the G0 subdomain of EF-G as well
as ribosomal proteins L7/L12. This finding supports the
idea that recycling of EF-G from the ribosome, which occurs
upon release of Pi, is mediated via the interaction of L7-CTD
with the G0 subdomain of EF-G. In contrast we can demon-
strate that Evn does not influence EF-G rdGTPase, or
EF-G dependent translocation, but is a potent inhibitor of
EF4-dependent back-translocation reaction as well as IF2-
dependent 70S-initiation complex formation. These findings
are in agreement with the predicted binding site of the ortho-
somycins relative to the binding sites of EF-G, EF4, and IF2
on the ribosome. Understandingmechanistically how antibi-
otics perturb the translational apparatus is an important
step for the future development of new improved antimicro-
bial agents to overcome the emerging resistant bacterial
pathogens.
EXPERIMENTAL PROCEDURES
Component Preparation
ThS was purchased from Sigma, MiC P1was a kind gift of Dr. Torsten Stachel-
haus, and gDNA from S. faecalis was kindly provided by Dr. Vincent Perreten.
E. coli fusA and bipA,S. faecalis tetM as well as T. thermophilus (HB8) fusA full-
length genes were cloned into pET-46 Ek/LIC vector, and E. coli infB gene was
cloned into pET-14b, in accordance with the manufacturer’s instructions
(Novagen). EF-GDG0 mutants were prepared using QuikChange Site-Directed
Mutagenesis Kit (Stratagene). E. coli EF4 was expressed in pET14b as
described previously (Qin et al., 2006). Recombinant proteins were expressed
in BL21 (DE3) cells, at 20C with 0.2 mM IPTG, then purified with a Ni2+-NTA
affinity column (QIAGEN), followed by gel-filtration chromatography on a
HiLoad 16/60 Superdex 75 prep grade column (Amersham-Pharmacia) in
a buffer containing 10 mM Tris (pH 7.8), 100 mM NaCl, and 10 mM 2-mercap-
toethanol. E. coli 70S ribosomes lacking L7/L12 were prepared as described
by Hamel et al. (1972) and Wystup et al. (1979). Tight-coupled E. coli589–600, May 27, 2011 ª2011 Elsevier Ltd All rights reserved 597
Chemistry & Biology
Thiopeptide and Orthosomycin Action on Ribosomesribosomes, cloned E. coli His-tagged proteins EF-G, EF-Tu, IF1, IF2, and IF3,
and E. coli [35S]fMet-tRNAfMet; E. coli [3H]Phe-tRNAPhe were prepared as
described (Liu et al., 2010). MFK-mRNA was purchased from Dharmacon
(Lafayette, CO, USA) with sequences 50-GGG AAG GAG GUA AAA AUG
UUU AAA CGU AAA UCU ACU-30 (initiator codon underlined).
IF2-Dependent 70SIC Formation Light-Scattering Assay
This assay was performed as described (Grigoriadou et al., 2007). 30SIC
was formed by mixing 0.3 mM 30S, 0.45 mM IF1, 0.45 mM IF3, 0.45 mM fMet-
tRNAf
Met, 0.15 mM IF2, 0.9 mM AUG022-mRNA (Grigoriadou et al., 2007),
and 100 mM GTP, premixed with various concentrations of Evn (0–5 mM) and
then rapidly mixed with 50S subunits (0.3 mM) in a KinTek stopped-flow spec-
trophotometer. Excitation was at 436 nm, and light scattering was determined
using a 455 nm cutoff filter. All concentrations are final after mixing.
Back-Translocation Assay
All of the following complexes were made up in buffer A (20 mM HEPES-KOH
[pH 7.5], at 0C, 150 mM NH4Ac, 4.5 mM MgAc2, 4 mM b-mercaptoethanol,
0.05 mM spermine, and 2 mM spermidine) at 37C. Initiation complex was
formed by incubating WT ribosomes (2 mM) with mRNA MFK (8 mM), IF1
(3 mM), IF2 (3 mM), IF3 (3 mM), GTP (1 mM), and [35S]fMet-tRNAfMet (3 mM) for
25 min. Ternary complex was formed by incubating EF-Tu (6 mM) with labeled
Phe-tRNAPhe (3 mM), GTP (1 mM), phosphoenolpyruvate (Roche Diagnostics)
(1.5 mM), and pyruvate kinase (Roche Diagnostics) (0.015 mg/ml) for 15 min.
POST complexes were formed by incubating ternary complex and initiation
complex at 37C briefly for 45 s and then in the presence of EF-G (molar ratio
of EF-G:ribosome was 0.2:1) and GTP (1 mM) at 37C for 10 min. Then they
were purified by ultracentrifugation through a 1.1 M Sucrose cushion in buffer
A (450,000 3 g, 40 min, 4C). POST complex concentration was calculated
from the amount of ribosome-bound fMet-[3H]Phe-tRNAPhe. Stopped-flow
fluorescence experiments were performed using an SX.18MV Stopped-Flow
Spectrofluorometer (Applied Photophysics). POST complex (0.1 mM) contain-
ing fMetPhe-tRNAPhe(Prf) in the P site and tRNAfMet in the E site was rapidly
mixed with 0.15 mM tRNAfMet, 3 mM EF4,GDPNP, and various concentrations
of Evn (0–5 mM). prf was excited at 460 nm, and fluorescence was monitored
using a 495 nm long-pass filter. Lines through the data are fit to triple-exponen-
tial equations using the program IGOR Pro (WaveMetrics).
Translocation Assay
PRE complexes were formed by incubating initiation complex and ternary
complex at 37C for 45 s. Then they were purified by ultracentrifugation
through a 1.1 M Sucrose cushion in buffer A with 20 mM Mg2+ (450,000 3 g,
40 min, 4C). PRE complex concentration was calculated from the amount
of ribosome-bound fMet-[3H]Phe-tRNAPhe. Stopped-flow fluorescence exper-
iments were performed using an SX.18MV Stopped-Flow spectrofluorometer.
prf was excited at 460 nm, and fluorescence was monitored using a 495 nm
long-pass filter. Data are fit to double-exponential equations using the
program IGOR Pro (WaveMetrics).
Malachite Green GTPase Activity Assays
GTPase activity was measured using the Malachite Green Phosphate Kit
(BioAssay) that quantifies the green complex formed between malachite
green, molybdate, and free orthophosphate. Unless otherwise mentioned, all
reactions contained 30 nM E. coli 70S ribosomes, 20 mM GTP, and 60 nM
protein in the presence or absence of antibiotics as necessary. Reactions
were transferred into 96-well microtiter plates, and color formation was
measured on Tecan Infinite M1000 microplate reader at 650 nm. Reactions
performed in the absence of ribosomes were used as a background signal
to account for the intrinsic GTPase activity of the translation factor.
In Vitro Transcription-Translation Assay
All coupled transcription-translation experiments were performed using an
E. coli lysate-based system in the presence and absence of antibiotics as
described previously (Starosta et al., 2009, 2010). Reactions were transferred
into 96-well microtiter plates, and the GFP fluorescence was measured with
a Typhoon Scanner 9400 (Amersham Bioscience) using a Typhoon blue laser
module (Amersham Bioscience). Images were then quantified using Image-598 Chemistry & Biology 18, 589–600, May 27, 2011 ª2011 ElsevierQuant TL (GEHealthcare) and represented graphically using SigmaPlot (Systat
Software, Inc.).
Figure Preparation
Chemical structures for the precursor compounds were drawn using
ChemDraw (Advanced Chemistry Development, Inc., Toronto, Canada), and
all structural figures were prepared with PyMOL (http://www.pymol.org).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.chembiol.2011.03.010.
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